| Piperazinedione compounds CM Teng, HP Wang, EIC Li, O Lee, JH Guh, HT Chen, YB Fan, YL Chen US Patent 6,635,649, 2003 | 65* | 2003 |
| Synthesis, DNA binding, and cytotoxicity of 1, 4-bis (2-amino-ethylamino) anthraquinone–amino acid conjugates LW Hsin, HP Wang, PH Kao, O Lee, WR Chen, HW Chen, JH Guh, ... Bioorganic & medicinal chemistry 16 (2), 1006-1014, 2008 | 53 | 2008 |
| Synthesis and structure–activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitors RR Khanwelkar, GS Chen, HC Wang, CW Yu, CH Huang, O Lee, ... Bioorganic & medicinal chemistry 18 (13), 4674-4686, 2010 | 30 | 2010 |
| Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitors CH Chen, O Lee, CN Yao, MY Chuang, YL Chang, MH Chang, YF Wen, ... Bioorganic & medicinal chemistry letters 20 (20), 6129-6132, 2010 | 27 | 2010 |
| Azaazulene compounds O Lee, CH Chen, CY Hung, YL Chang, TS Chen US Patent 8,492,374, 2013 | 25 | 2013 |
| Synthesis of 1-substituted 3-pyridinylmethylidenylindolin-2-ones and 1-substituted 3-quinolinylmethylidenylindolin-2-ones as the enhancers of ATRA-induced differentiation in HL … CY Hung, MH Hsu, LJ Huang, CS Hwang, O Lee, CY Wu, CH Chen, ... Bioorganic & medicinal chemistry 16 (8), 4222-4232, 2008 | 17 | 2008 |
| Selective cytotoxicity of azatyrosinamides against ras-transformed NIH 3T3 cells HP Wang, TL Hwang, O Lee, YJ Tseng, CY Shu, SJ Lee Bioorganic & medicinal chemistry letters 15 (19), 4272-4274, 2005 | 6 | 2005 |
| Novel piperazinediones as antitumor agents CL Wang, O Lee, G Hsiao, JF Lian, YW Cheng Anticancer Research 34 (8), 4013-4019, 2014 | 4 | 2014 |
| Anticholesteremic compounds HP Wang, O Lee, CT Fan US Patent 5,530,145, 1996 | 4 | 1996 |
| Azatyrosinamides: Novel RAS-related anticancer agents CL Wang, O Lee, CF Huang, EIC LI, CM Teng, SL Pan, JF Lian, FS Chang, ... Anticancer Research 33 (2), 425-432, 2013 | 2 | 2013 |
| Azulene-oxindole compounds as multiple-kinase inhibitors and useful as anticancer agents O Lee, CS Hwang, CH Chen, YJ Tsai, CP Liu, CH Ko, HH Shen, LM Wang, ... US Patent 7,714,146, 2010 | 2 | 2010 |
| Oligopeptide, derivatives thereof, and pharmaceutical composition comprising the same O Lee, JT Hwang, CS Hwang, YJ Tsai, CY Su, TL Hu, SM Wu, C Lin US Patent App. 11/440,174, 2007 | 2 | 2007 |
| A Convenient Synthesis of Antihyperlipoproteinemic Agent Gemfibrozil HP Wang, O Lee, CT Fan, LT Lee Journal of the Chinese Chemical Society 42 (3), 569-572, 1995 | 2 | 1995 |
| Derivatives and preparation of 2, 2-dimethyl-5-substituted phenoxy-pentanoic acids HP Wang, O Lee, CT Fan US Patent 5,412,112, 1995 | 2 | 1995 |
| Antibody-drug conjugate (ADC) and method for forming the same YJ Ko, LI Jheng-Sian, LU Maggie, O Lee, PF Cheng, CM Liu US Patent 10,618,935, 2020 | 1 | 2020 |
| NAP derivatives O Lee, JT Hwang, CS Hwang, YJ Tsai, CY Su, TL Hu, SM Wu, CH Lin US Patent 7,544,666, 2009 | 1 | 2009 |
| Synthesis of indole analogs of 1-benzyl-3-(5′-hydroxymethyl-2′-furyl) indazole (YC-1) as anti-platelet agents SC Kuo, FY Lee, TM Huang, CM Teng, O Lee, CY Wu, CS Hwang, ... US Patent 7,176,230, 2007 | 1 | 2007 |
| Piperazinedione compounds CM Teng, HP Wang, EIC Li, O Lee, JH Guh, HT Chen, YB Fan, YL Chen | 1 | 2001 |
| Compounds, linker-drugs and ligand-drug conjugates O Lee, T Mei-Hsuan US Patent 10,683,327, 2020 | | 2020 |
| Compounds, linker-drugs and ligand-drug conjugates O Lee, T Mei-Hsuan US Patent 10,233,212, 2019 | | 2019 |
